Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boehringer ingelheim
3
×
boston
3
×
boston blog main
boston top stories
deals
life sciences
national blog main
alexion pharmaceuticals
biotech
clinical trials
eli lilly
hepatitis b
national top stories
rna interference
san francisco blog main
san francisco top stories
alnylam pharmaceutials
alnylam pharmaceuticals
arrowhead pharmaceuticals
biontech
curevac
dicerna pharamceuticals
dicerna pharmaceuticals
fda
hepatitis b virus
hereditary transthyretin amyloidosis
indiana blog main
indiana top stories
infectious diseases
john shiver
johnson & johnson
moderna therapeutics
mrna
neurodegenerative diseases
new york blog main
new york top stories
patisiran
primary hyperoxaluria
roche
sanofi
What
medicines
3
×
companies
deal
dicerna
pharma
rna
abandoning
ago
baggage
bets
bio
cancer
caught
causing
comes
cut
cuts
date
development
disease
drug
effective
enticed
evidence
eye
free
gene
gets
hasn’t
hepatitis
intended
interference
latest
long
messenger
molecules
mrna
multiple
new
pay
Language
unset
Current search:
medicines
×
photo
×
boston
×
" boehringer ingelheim "
×
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
